Spero Therapeutics (SPRO) Enterprise Value Growth (1y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Spero Therapeutics | 162.39 Mn | 106.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.81% |
| Dec 31, 2025 | 23.87% |
| Sep 30, 2025 | 36.27% |
| Jun 30, 2025 | 50.90% |
| Mar 31, 2025 | 40.58% |
| Dec 31, 2024 | 30.71% |
| Sep 30, 2024 | 18.69% |
| Jun 30, 2024 | 18.23% |
| Mar 31, 2024 | 14.53% |
| Dec 31, 2023 | 30.04% |
| Sep 30, 2023 | -85.99% |
| Jun 30, 2023 | -71.12% |
| Mar 31, 2023 | 21.08% |
| Dec 31, 2022 | 25.47% |
| Sep 30, 2022 | 59.13% |
| Jun 30, 2022 | 54.24% |
| Mar 31, 2022 | -5.44% |
| Dec 31, 2021 | -15.36% |
| Sep 30, 2021 | 3.01% |
| Jun 30, 2021 | -39.04% |
| Mar 31, 2021 | -30.21% |
| Dec 31, 2020 | -54.68% |
| Sep 30, 2020 | -36.09% |
| Jun 30, 2020 | 30.75% |
| Mar 31, 2020 | 16.22% |
| Dec 31, 2019 | 28.71% |
| Sep 30, 2019 | 28.55% |
| Jun 30, 2019 | -55.48% |
| Mar 31, 2019 | -41.31% |
| Dec 31, 2018 | -32.39% |
| Sep 30, 2018 | -423.23% |
| Jun 30, 2018 | -1,135.66% |
| Dec 31, 2017 | -515.54% |
| Sep 30, 2017 | -121.74% |